cdmo.directory
← Compare landing

Grifols Partnership vs Rentschler Biopharma SE

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryGrifols PartnershipRentschler Biopharma SE
SummaryCDMO specializing in small molecule injectable products, including concentrated and diluted parenteral formulations and intravenous solutions, leveraging 100+ years of Grifols expertise.Rentschler Biopharma is a family-owned CDMO offering bioprocess development and manufacturing of biopharmaceuticals, with about 50 years of experience. It operates sites in Laupheim, Germany and Milford, Massachusetts, USA.
Services
  • Small Molecule Development & Manufacturing
  • API Synthesis & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • CMC Regulatory Submission Support
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • Biologics Development & Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • Formulation Development
  • CMC Analytical Development
  • CMC Regulatory Submission Support
Modalities
  • Small Molecule
  • Biologics (Other)
  • Biologics (Other)
Development capabilities
  • Formulation development
  • Analytical method development
  • Formulation development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
Data not yet provided.
Locations
  • Headquarters, Sant Cugat del Vallès, Catalonia, Spain
  • Headquarters, Laupheim, Baden-Württemberg, Germany
  • Milford, Milford, Massachusetts, USA
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Grifols Partnership alternatives · Rentschler Biopharma SE alternatives

Markdown mirror: /compare/grifols/rentschler-biopharma.md